Eric Whitman

7PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Semi- and unsupervised learningMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 02, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study.

Theresa Medina, Jason A Chesney, Harriet M Kluger

|Jan 05, 2023
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study.

Jason Chesney, Karl D Lewis, Harriet Kluger

|Mar 30, 2022
RE: More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 patients.

Eric D Whitman, J Michael Guenther

|Dec 30, 2021
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial.

Ezra E W Cohen, Lisle Nabell, Deborah J Wong

|Sep 27, 2021
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction.

Eric D Whitman, Vadim P Koshenkov, Brian R Gastman

|Aug 31, 2021
Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma.

Robert H I Andtbacka, Brendan Curti, Gregory A Daniels

Pageof 2

Frequent Collaborators

3 joint publications

Amod Sarnaik

3 joint publications

Evidio Domingo-Musibay

2 joint publications

Omid Hamid

2 joint publications

Nikhil I Khushalani